Christof Schaefer
Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie
Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy
Spandauer Damm 130
Berlin
Germany
Name/email consistency: high
- Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services. Schaefer, C. Congenit. Anom. (Kyoto) (2011)
- Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Schaefer, C., Meister, R., Weber-Schoendorfer, C. Arch. Gynecol. Obstet. (2010)
- Fetal outcome after technetium scintigraphy in early pregnancy. Schaefer, C., Meister, R., Wentzeck, R., Weber-Schoendorfer, C. Reprod. Toxicol. (2009)
- Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations. Schaefer, C., Ornoy, A., Clementi, M., Meister, R., Weber-Schoendorfer, C. Reprod. Toxicol. (2008)
- Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Schaefer, C., Hannemann, D., Meister, R., Eléfant, E., Paulus, W., Vial, T., Reuvers, M., Robert-Gnansia, E., Arnon, J., De Santis, M., Clementi, M., Rodriguez-Pinilla, E., Dolivo, A., Merlob, P. Thromb. Haemost. (2006)
- Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS. Schaefer, C., Hannemann, D., Meister, R. Reprod. Toxicol. (2005)
- Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Schaefer, C. Birth Defects Res. Part A Clin. Mol. Teratol. (2003)









